Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Semba

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|August 8, 2022
c-kit inhibitor masitinib induces reactive oxygen species-dependent apoptosis in c-kit-negative HepG2 cellsYuta Semba, Shintaro Yamamoto, Shunsuke Takahashi, et al.
European Journal of Pharmacology|August 22, 2025
Ridaifen derivatives function as potent lysosomotropic agents, depending on their basic side chainsYuta Semba, Kyoka Komukai, Eri Murata, et al.
Frontiers in Chemistry|September 9, 2024
Synthesis of BODIPY FL-tethered ridaifen-B, RID-B-BODIPY, and its localization in cancer cellsTakatsugu Murata, Kyoka Komukai, Yuta Semba, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|August 8, 2022
c-kit inhibitor masitinib induces reactive oxygen species-dependent apoptosis in c-kit-negative HepG2 cellsYuta Semba, Shintaro Yamamoto, Shunsuke Takahashi, et al.
European Journal of Pharmacology|August 22, 2025
Ridaifen derivatives function as potent lysosomotropic agents, depending on their basic side chainsYuta Semba, Kyoka Komukai, Eri Murata, et al.
Frontiers in Chemistry|September 9, 2024
Synthesis of BODIPY FL-tethered ridaifen-B, RID-B-BODIPY, and its localization in cancer cellsTakatsugu Murata, Kyoka Komukai, Yuta Semba, et al.
Pageof 1